Non-invasive assessment of liver steatosis and fibrosis in HIV/HCV- and HCV- infected patients
Journal Title: Annals of Hepatology - Year 2013, Vol 12, Issue 5
Abstract
Background. Conflicting data have been reported on the prevalence of liver steatosis, its risk factors and its relationship with fibrosis in patients with human immunodeficiency virus (HIV)/hepatitis C virus (HCV) co-infection or with HCV mono-infection. Aim. The study aims were to assess steatosis prevalence and its risk factors in both HCV groups. We also evaluated whether steatosis was linked with advanced fibrosis. Sixty-eight HIV/HCV co-infected and 69 HCV mono-infected patients were consecutively enrolled. They underwent liver ultrasonography and transient elastography. Bright liver echo-pattern was used to diagnose steatosis; advanced fibrosis was defined as liver stiffness ≥ 9.5 kPa and FIB-4 values ≥ 3.25. The optimal stiffness cut-off according to FIB-4 ≥ 3.25 was evaluated by ROC analysisResults. No significant difference was found in steatosis-prevalence between mono- and co-infected patients (46.3 vs. 51.4%). Steatosis was associated with triglycerides and impaired fasting glucose/diabetes in HCV mono-infected, with lipodystrophy, metabolic syndrome, total-cholesterol and triglycerides in co-infected patients. Stiffness ≥ 9.5 was significantly more frequent in co-infection (P < 0.003). Advanced fibrosis wasn’t significantly associated with steatosis. The area under the ROC curve was 0.85 (95% CI 0.79-0.9). On multivariate analysis steatosis was associated with triglycerides in both HCV mono- and co-infected groups (P < 0.02; P < 0.03).Conclusion. Although steatosis was common in both HCV mono- and co-infected patients, it was not linked with advanced fibrosis. Triglycerides were independent predictors of steatosis in either of the HCV-groups. Dietary interventions and lifestyle changes should be proposed to prevent metabolic risk factors.
Authors and Affiliations
Valentina Li Vecchi, Lydia Giannitrapani, Paola Di Carlo, Giovanni Mazzola, Pietro Colletti, Emanuele La Spada, Giuseppe Montalto, Maurizio Soresi
Keywords
Related Articles
- EP ID EP78314
- DOI -
- Views 132
- Downloads 0
Sarcopenia predicts reduced survival in patients with hepatocellular carcinoma at first diagnosis
Background. Sarcopenia is a complication and independent risk factor for mortality in patients with liver cirrhosis. Aim. To assessthe prevalence and influence of sarcopenia on overall survival in a cohort of cirrhotic...
Extracorporeal liver support-albumin dialysis with the Molecular Adsorbent Recirculating System (MARS)
Extracorporeal liver support has been a much studied topic throughout the last 50 years. Albumin dialysis as a therapeutic option for patients with acute liver failure or acute decompensation of chronic liver disease was...
Estimated time from clinical presentation to the development of cirrhosis in non-cirrhotic adult patients with non-alcoholic fatty liver disease
Epidemiological assessment of liver disease in northeastern Brazil by means of a standardized liver biopsy protocol
Background. Intestinal intussusception in adults is associated with chronic inflammatory bowel disease, celiac disease, abdominal tumors or previous abdominal surgery but most often of unknown origin. Aim. The aim of our...
Nonalcoholic fatty liver disease in asymptomatic obese women
Objective. To determine the clinical characteristics of NAFLD in asymptomatic obese women. Methods. A total of 457 asymptomatic obese women were enrolled in a cross-sectional study and allocated into groups with and with...